Infection of 5xFAD mice with a mouse-adapted SARS-CoV-2 does not alter Alzheimer's disease neuropathology yet induces wide-spread changes in gene expression across diverse cell types
Susana FurmaniD, Latifa ZayouiD, Kate Inman TsourmasiD, Dominic I. JavonilloiD, Gema M. Olivarria, Yuting Cheng, Collin PachowiD, Kellie Fernandez, Lucas LeiD, Robert A. EdwardsiD, Dequina NicholasiD, Gabriela Pacheco SancheziD, Ralph Steven BariciD, Kim N. GreeniD, Thomas E. LaneiD
Abstract
Alzheimers disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia. It is characterized by cognitive decline and accumulation of amyloid beta (A{beta}) plaques and neurofibrillary tangles. Accumulating evidence indicates that viral infection may worsen and/or increase development of established AD pathology. The COVID-19 pandemic has brought attention to the link between SARS-CoV-2 infection and neurologic conditions that vary in severity and duration, as well as the worsening of clinical symptoms in elderly people with dementia. To better understand potential mechanisms by which SARS-CoV-2 infection impacts AD neuropathology, aged 5xFAD and wildtype (WT) mice were intranasally infected with mouse-adapted SARS-CoV-2 (MA10). Intranasal infection of aged-matched (10-14 month) 5xFAD or wild type (WT) C57BL/6 mice with MA10 resulted in viral infection of the lungs that correlated with acute viral pneumonia characterized by lymphocyte inflammation and antiviral immune responses. Viral RNA was not detected within the central nervous system (CNS) of either WT or 5xFAD mice at days 7 or 21 post-infection (p.i.), nor were there signs of overt glial activation or neuroinflammation. There were no differences in either A{beta} plaque volume or number within the brains of MA10-infected 5xFAD mice compared to uninfected 5xFAD mice. However, bulk RNA sequencing and spatial transcriptomics revealed evidence of altered expression of genes associated with neuronal and glial dysfunction, as well as reduced expression of genes encoding adhesion molecules in vascular endothelial cells. Collectively, these findings demonstrate that MA10 infection did not affect A{beta} plaque size or numbers in 5xFAD mice, yet in both WT and 5xFAD mice, there were numerous down-stream effects on gene expression associated with resident CNS cell function.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Accelerated amyloid deposition in SARS-CoV-2 infected mouse models of Alzheimer's disease
Parag A Parekh, Andrew Badachhape, … Ananth Annapragada·bioRxiv·Dec 9, 2024
- Characterization of effects of a neurotropic murine coronavirus infection on Alzheimer's disease neuropathology of 5xFAD mice
Dominic I. Javonillo, Susana Furman, … Thomas E. Lane·bioRxiv·Feb 25, 2026
- Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Yadi Zhou, Jielin Xu, … Feixiong Cheng·Alzheimer s Research & TherapyPeer-reviewed·Jun 9, 2021
- Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer's disease individuals
Elizabeth Griggs, Kyle J. Trageser, … Giulio Maria Pasinetti·eLifePeer-reviewed·Jun 28, 2023
- Mouse Adapted SARS-CoV-2 Model Induces "Long-COVID" Neuropathology in BALB/c Mice
Timothy E. Gressett, Sarah R. Leist, … Gregory Jaye Bix·bioRxiv·Mar 18, 2023
- Higher Angiotensin I Converting Enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.
Louise Réveret, Leclerc Manon, … Calon Frédéric·bioRxiv·Jan 17, 2023